Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in OVID — Ovid Therapeutics Inc.

CIK 1166588 NEW YORK, NY

Position in OVID

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$64,226
+$62,024 QoQ
Shares Held
23,876
+2306.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in OVID Over Time

Shares Held

Position Value (USD)

Derivatives in OVID

reported options exposure · as of Dec 31, 2020
CallValue
$462
CallShares
200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,275,701,265 across 414 Biotechnology names. OVID ranks #251 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OVID

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $64,226 23,876
2026-03-31 $2,202 992
2025-12-31 $1,597 980
2025-09-30 $1,250 962
2025-06-30 $286 867
2025-03-31 $20,889 66,953
2024-12-31 $97,801 104,712
2024-09-30 $260,073 220,401
2024-06-30 $4,008 5,212
2024-03-31 $98,094 32,162
2023-12-31 $59,267 18,406
2023-09-30 $33,216 8,650
2023-06-30 $50,856 15,505
2023-03-31 $2 1
2022-12-31 $1 1
2022-09-30 $292 159
2022-06-30 $2,306 1,073
2022-03-31 $197 63
2021-12-31 $202 63
2021-09-30 $211 63
2021-06-30 $13,426 3,434
2021-03-31 $23,613 5,874
2020-12-31 $20,129 8,714
2020-12-31 $462 200
2020-09-30 $56,033 9,762
2020-06-30 $11,821 1,604
2020-03-31 $208 70